Zanamivir

Zanamivir is a medication used to treat and prevent influenza caused by influenza A and B viruses. It is a neuraminidase inhibitor and was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B.[1] Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithK... [wikipedia]